...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Successful Single-kidney Transplantation in Adult Recipients Using Pediatric Donors Aged 8 to 36 Months: Comparable Outcomes With Those Using Pediatric Donors Aged >3 Years
【24h】

Successful Single-kidney Transplantation in Adult Recipients Using Pediatric Donors Aged 8 to 36 Months: Comparable Outcomes With Those Using Pediatric Donors Aged >3 Years

机译:使用8至36个月的儿科捐助者成人受者的成功单肾移植:使用儿科捐赠者的比较成果> 3年

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background. Using pediatric donors for single-kidney transplantation (SKT) can increase the number of possible recipients. However, it is unclear when SKT involving small pediatric donors and adult recipients can safely be performed without compromising graft outcome. Methods. From 2013 to 2017, a total of 102 SKTs in adult recipients were performed in our center using pediatric donors aged <12 years. We compared the outcomes from donors aged 8 to 36 months (the small-kidney group [SKG], n = 46) and from donors aged 3 to 12 years (the big-kidney group [BKG], n = 56). The median follow-up time was 30 months in the SKG and 28 months in the BKG. Results. All patients achieved satisfactory renal function after transplantation, despite the fact that some patients (SKG, 19.6%; BKG, 28.6%) developed delayed graft function. One-year graft survival and death-censored graft survival in the SKG were 89.1% and 100%, respectively, comparable to the results in the BKG (92.9% and 98.2%). One year later, the graft and patient survival rates in both groups remained unchanged. Pulmonary infection was the main cause of death in patients with a functioning graft (SKG, 4 patients; BKG, 2 patients). Proteinuria occurred early in some patients (SKG, 30.4%; BKG, 19.6%) and decreased gradually within the first year posttransplantation. Conclusions. SKT from pediatric donors aged 8 to 36 months to selected adult recipients produced excellent intermediate-term outcomes, comparable with those when older pediatric donors were used. This study provides evidence to support a lower age limit for SKT from pediatric donors.
机译:背景。使用儿科供体用于单肾移植(SKT)可以增加可能的收件人的数量。然而,涉及涉及小儿科供体和成人接受者的SKT可以安全地进行,而不会损害移植结果。方法。从2013年到2017年,我们的中心共有102个SKTS在我们的中心使用<12年来的儿科捐助者进行。将8至36个月(小肾脏组[SKG],N = 46)的捐赠者的结果与3至12年的捐助者进行了比较(大肾组[BKG],N = 56)。中位后续时间在SKG和BKG中的28个月内为30个月。结果。所有患者在移植后所有患者都取得了令人满意的肾功能,尽管有些患者(SKG,19.6%; BKG,28.6%)出现延迟移植物功能。 SKG中一年的移植物存活和死亡丧情的移植物存活分别为89.1%和100%,与BKG的结果相当(92.9%和98.2%)。一年后,两组的移植物和患者存活率保持不变。肺部感染是具有运作移植物(SKG,4名患者; BKG,2名患者)的患者死亡的主要原因。蛋白尿在一些患者早期发生(SKG,30.4%; BKG,19.6%)并在持续的第一年内逐渐下降。结论。 SKT从8至36个月的儿科捐赠者到选定的成人受体产生优异的中期结果,与使用较旧的小儿主供应者的使用相当。本研究提供了支持来自儿科捐助者的SKT的较低年龄限制的证据。

著录项

  • 来源
  • 作者单位

    Huazhong Univ Sci &

    Technol Tongji Hosp Tongji Med Coll Inst Organ Transplantat Wuhan Peoples;

    Huazhong Univ Sci &

    Technol Tongji Hosp Tongji Med Coll Inst Organ Transplantat Wuhan Peoples;

    Huazhong Univ Sci &

    Technol Tongji Hosp Tongji Med Coll Inst Organ Transplantat Wuhan Peoples;

    Huazhong Univ Sci &

    Technol Tongji Hosp Tongji Med Coll Inst Organ Transplantat Wuhan Peoples;

    Huazhong Univ Sci &

    Technol Tongji Hosp Tongji Med Coll Inst Organ Transplantat Wuhan Peoples;

    Huazhong Univ Sci &

    Technol Tongji Hosp Tongji Med Coll Inst Organ Transplantat Wuhan Peoples;

    Huazhong Univ Sci &

    Technol Tongji Hosp Tongji Med Coll Inst Organ Transplantat Wuhan Peoples;

    Huazhong Univ Sci &

    Technol Tongji Hosp Tongji Med Coll Inst Organ Transplantat Wuhan Peoples;

    Huazhong Univ Sci &

    Technol Tongji Hosp Tongji Med Coll Inst Organ Transplantat Wuhan Peoples;

    Huazhong Univ Sci &

    Technol Tongji Hosp Tongji Med Coll Inst Organ Transplantat Wuhan Peoples;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 器官移植术;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号